Treatment of locally advanced breast cancer
- PMID: 15289404
- PMCID: PMC490054
- DOI: 10.1503/cmaj.1040532
Treatment of locally advanced breast cancer
Comment on
-
Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer.CMAJ. 2004 Mar 16;170(6):983-94. doi: 10.1503/cmaj.1030944. CMAJ. 2004. PMID: 15023926 Free PMC article.
Similar articles
-
Treatment of locally advanced breast cancer.CMAJ. 2004 Aug 3;171(3):219-20; author reply 221-2. doi: 10.1503/cmaj.1040624. CMAJ. 2004. PMID: 15289403 Free PMC article. No abstract available.
-
[The development of breast cancer therapy in Germany in 2004].Gynakol Geburtshilfliche Rundsch. 2004 Apr;44(2):61-2. doi: 10.1159/000076858. Gynakol Geburtshilfliche Rundsch. 2004. PMID: 15067227 German. No abstract available.
-
[Taxanes as adjuvants in breast cancer. What repercussions will this have in clinical practice?].Suppl Tumori. 2004 Jul-Aug;3(4):S18-20. Suppl Tumori. 2004. PMID: 15206203 Review. Italian. No abstract available.
-
Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):283-9. Eur Rev Med Pharmacol Sci. 2007. PMID: 18074936 Review.
-
Treatment of locally advanced breast cancer.CMAJ. 2004 Aug 3;171(3):220-1; author reply 221-2. doi: 10.1503/cmaj.1040625. CMAJ. 2004. PMID: 15289405 Free PMC article. No abstract available.
References
-
- Shenkier T, Weir L, Levine M, Olivetto I, Whelan T, Reyno L; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ 2004;170(6):983-94. - PMC - PubMed
-
- O'Rourke MW. Rebuilding a professional practice model. The return of role-based practice accountability. Nurs Admin Q 2003;27(2):95-105. - PubMed
-
- Ellis MJ, Coop A, Singh B, Mauriac L, Llombert-Cussac A, Janicke F, et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol 2001;19(18):3808-16. - PubMed
-
- Smith I, Dowsett M; IMPACT Trialists. Comparison of anastrozole vs tamoxifen alone and in combination as neoadjuvant treatment of estrogen receptor-positive (ER+) operable breast cancer in postmenopausal women: the IMPACT trial [abstract]. Breast Cancer Res Treat 2003;82 (Suppl 1):S6.
-
- Baum M, Buzdar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, et al; ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002;359:2131-9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical